tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Danielle Brill, 53 are a HOLD (17.85%), 239 are a BUY (80.47%), 5 are a SELL (1.68%).
Analyst Danielle Brill, currently employed at TRUIST, carries an average stock price target met ratio of 51.97% that have a potential upside of 30.22% achieved within 215 days.
Danielle Brill’s has documented 554 price targets and ratings displayed on 38 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ARGX, argenx NV ADR at 18-Aug-2026.
Analyst best performing recommendations are on AGIO (AGIOS PHARM).
The best stock recommendation documented was for AGIO (AGIOS PHARM) at 10/31/2024. The price target of $51 was fulfilled within 6 days with a profit of $6.57 (14.79%) receiving and performance score of 24.65.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-Dec-2025
$33
$13.05 (65.41%)
$37
8 days ago
(25-Sep-2026)
0/3 (0%)
$12.32 (59.57%)
Buy Since 17-Apr-2025
$34
$14.05 (70.43%)
$36
8 days ago
(25-Sep-2026)
4/6 (66.67%)
$13.32 (64.41%)
144
Buy Since 25-Sep-2025
$31
$11.05 (55.39%)
$38
8 days ago
(25-Sep-2026)
2/6 (33.33%)
$10.32 (49.90%)
574
Buy Since 26-Nov-2019
$33
$13.05 (65.41%)
$36
8 days ago
(25-Sep-2026)
9/25 (36%)
$12.32 (59.57%)
238
Buy Since 28-Feb-2024
$35
$15.05 (75.44%)
$41
8 days ago
(25-Sep-2026)
9/15 (60%)
$14.32 (69.25%)
393
Which stock is Danielle Brill most bullish on?
Which stock is Danielle Brill most reserved on?
What Year was the first public recommendation made by Danielle Brill?
